Compass Therapeutics (CMPX)

EBITDA Growth

-26.98%

Quarterly · Period ending:

CMPX logo

CMPX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-26.98%
CMPX Quarterly EBITDA YoY % (43.91% → -26.98%)
High-resolution chart · PNG

CMPX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Compass Therapeutics EBITDA Growth — Quarterly
Period endingEBITDA Growth
-26.9755%
-10.3264%
-4.5795%
-38.6581%
-54.7502%
-57.5843%
-13.339%
-5.4538%
-16.7268%
-40.348%
-16.5347%
12.5817%
-42.6704%
-9.6765%
11.5375%
-97.8692%
86.3002%
2.33%
-82.5171%
35.4228%
-1,036.7956%
-21.6044%
-18.6993%
-10.8894%
-1,072.4%
43.9114%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.